BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cerhan JR, Slager SL. Familial predisposition and genetic risk factors for lymphoma. Blood. 2015;126:2265-2273. [PMID: 26405224 DOI: 10.1182/blood-2015-04-537498] [Cited by in Crossref: 72] [Cited by in F6Publishing: 43] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Feng Q, Nickels E, Muskens IS, de Smith AJ, Gauderman WJ, Yee AC, Ricker C, Mack T, Leavitt AD, Godley LA, Wiemels JL. Increased burden of familial-associated early-onset cancer risk among minority Americans compared to non-Latino Whites. Elife 2021;10:e64793. [PMID: 34155975 DOI: 10.7554/eLife.64793] [Reference Citation Analysis]
2 Puente XS, Jares P, Campo E. Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions. Blood 2018;131:2283-96. [PMID: 29666114 DOI: 10.1182/blood-2017-10-764373] [Cited by in Crossref: 58] [Cited by in F6Publishing: 40] [Article Influence: 19.3] [Reference Citation Analysis]
3 Hallek M, Shanafelt TD, Eichhorst B. Chronic lymphocytic leukaemia. Lancet 2018;391:1524-37. [PMID: 29477250 DOI: 10.1016/S0140-6736(18)30422-7] [Cited by in Crossref: 95] [Cited by in F6Publishing: 53] [Article Influence: 31.7] [Reference Citation Analysis]
4 Cerhan JR, Habermann TM. Epidemiology of Marginal Zone Lymphoma. Ann Lymphoma 2021;5:1. [PMID: 33829216 DOI: 10.21037/aol-20-28] [Reference Citation Analysis]
5 Jasek M, Bojarska-Junak A, Sobczyński M, Wagner M, Chocholska S, Roliński J, Wołowiec D, Karabon L. Association of Common Variants of TNFSF13 and TNFRSF13B Genes with CLL Risk and Clinical Picture, as Well as Expression of Their Products-APRIL and TACI Molecules. Cancers (Basel) 2020;12:E2873. [PMID: 33036273 DOI: 10.3390/cancers12102873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 El Demerdash DM, Tawfik NM, Elazab R, El Sissy MH. The Association of Pre-diagnostic Inflammatory Markers and Adipokines and the Risk of Non-Hodgkin Lymphoma Development in Egypt. Indian J Hematol Blood Transfus 2021;37:76-81. [PMID: 33707838 DOI: 10.1007/s12288-020-01305-9] [Reference Citation Analysis]
7 Nagpal P, Akl MR, Ayoub NM, Tomiyama T, Cousins T, Tai B, Carroll N, Nyrenda T, Bhattacharyya P, Harris MB, Goy A, Pecora A, Suh KS. Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine. Oncotarget 2016;7:67551-73. [PMID: 27563824 DOI: 10.18632/oncotarget.11509] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
8 Teras LR, Desantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes: 2016 US Lymphoid Malignancy Statistics by World Health Organization Subtypes. CA: A Cancer Journal for Clinicians 2016;66:443-59. [DOI: 10.3322/caac.21357] [Cited by in Crossref: 389] [Cited by in F6Publishing: 331] [Article Influence: 77.8] [Reference Citation Analysis]
9 Tresckow JV, Eichhorst B, Bahlo J, Hallek M. The Treatment of Chronic Lymphatic Leukemia. Dtsch Arztebl Int 2019;116:41-6. [PMID: 30855005 DOI: 10.3238/arztebl.2019.0041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Attarbaschi A, Carraro E, Abla O, Barzilai-Birenboim S, Bomken S, Brugieres L, Bubanska E, Burkhardt B, Chiang AK, Csoka M, Fedorova A, Jazbec J, Kabickova E, Krenova Z, Lazic J, Loeffen J, Mann G, Niggli F, Miakova N, Osumi T, Ronceray L, Uyttebroeck A, Williams D, Woessmann W, Wrobel G, Pillon M; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfur t-Münster (i-BFM) Study Group. Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents. Haematologica 2016;101:1581-91. [PMID: 27515251 DOI: 10.3324/haematol.2016.147116] [Cited by in Crossref: 39] [Cited by in F6Publishing: 19] [Article Influence: 7.8] [Reference Citation Analysis]
11 Chiu YH, Bertrand KA, Zhang S, Laden F, Epstein MM, Rosner BA, Chiuve S, Campos H, Giovannucci EL, Chavarro JE, Birmann BM. A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma. Int J Cancer 2018;143:1914-22. [PMID: 29756258 DOI: 10.1002/ijc.31602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
12 Feurstein S, Drazer MW, Godley LA. Genetic predisposition to leukemia and other hematologic malignancies. Seminars in Oncology 2016;43:598-608. [DOI: 10.1053/j.seminoncol.2016.10.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
13 Zhai K, Chang J, Hu J, Wu C, Lin D. Germline variation in the 3'-untranslated region of the POU2AF1 gene is associated with susceptibility to lymphoma. Mol Carcinog 2017;56:1945-52. [PMID: 28345816 DOI: 10.1002/mc.22652] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Beekman R, Campo E. Shelterins, a genetic crossroad in CLL. Blood 2016;128:2279-80. [PMID: 28829750 DOI: 10.1182/blood-2016-09-735688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Uzoma IC, Taiwo IA, Granai M, Di Stefano G, Sorrentino E, Mannucci S, Durosinmi MA, Lazzi S, Leoncini L, Akinloye O. Distinct pattern of lymphoid neoplasms characterizations according to the WHO classification (2016) and prevalence of associated Epstein-Barr virus infection in Nigeria population. Infect Agent Cancer 2021;16:36. [PMID: 34030716 DOI: 10.1186/s13027-021-00378-z] [Reference Citation Analysis]
16 Carbone A, Roulland S, Gloghini A, Younes A, von Keudell G, López-guillermo A, Fitzgibbon J. Follicular lymphoma. Nat Rev Dis Primers 2019;5. [DOI: 10.1038/s41572-019-0132-x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 22.0] [Reference Citation Analysis]
17 Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and Etiology of Leukemia and Lymphoma. Cold Spring Harb Perspect Med 2020;10:a034819. [PMID: 31727680 DOI: 10.1101/cshperspect.a034819] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
18 Dong Y, Shi O, Zeng Q, Lu X, Wang W, Li Y, Wang Q. Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol 2020;9:14. [PMID: 32577323 DOI: 10.1186/s40164-020-00170-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
19 Kipps TJ, Stevenson FK, Wu CJ, Croce CM, Packham G, Wierda WG, O'Brien S, Gribben J, Rai K. Chronic lymphocytic leukaemia. Nat Rev Dis Primers 2017;3:16096. [PMID: 28102226 DOI: 10.1038/nrdp.2016.96] [Cited by in Crossref: 174] [Cited by in F6Publishing: 129] [Article Influence: 43.5] [Reference Citation Analysis]
20 Kleinstern G, Yan H, Hildebrandt MAT, Vijai J, Berndt SI, Ghesquières H, McKay J, Wang SS, Nieters A, Ye Y, Monnereau A, Brooks-Wilson AR, Lan Q, Melbye M, Jackson RD, Teras LR, Purdue MP, Vajdic CM, Vermeulen RCH, Giles GG, Cocco PL, Birmann BM, Kraft P, Albanes D, Zeleniuch-Jacquotte A, Crouch S, Zhang Y, Sarangi V, Asmann Y, Offit K, Salles G, Wu X, Smedby KE, Skibola CF, Slager SL, Rothman N, Chanock SJ, Cerhan JR. Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways. Hum Mol Genet 2020;29:70-9. [PMID: 31600786 DOI: 10.1093/hmg/ddz228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
21 Haas OA. Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework. Front Immunol 2018;9:3136. [PMID: 30809233 DOI: 10.3389/fimmu.2018.03136] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
22 Ghamlouch H, Nguyen-khac F, Bernard OA. Chronic lymphocytic leukaemia genomics and the precision medicine era. Br J Haematol 2017;178:852-70. [DOI: 10.1111/bjh.14719] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
23 Kleinstern G, Abu Seir R, Perlman R, Khatib A, Abdeen Z, Elyan H, Nirel R, Amir G, Ramlawi A, Sabatin F, Boffetta P, Dann EJ, Kedmi M, Ellis M, Nagler A, Ben Yehuda D, Paltiel O. Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians. PLoS One 2017;12:e0171709. [PMID: 28196110 DOI: 10.1371/journal.pone.0171709] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
24 Meacham PJ, Williams AM, Strawderman M, Baran AM, Archibald WJ, Wallace DS, Tschernia NP, Burack WR, Barr PM, Zent CS. Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL). Leuk Lymphoma 2020;61:1636-44. [PMID: 32175786 DOI: 10.1080/10428194.2020.1737690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Odutola MK, Benke G, Fritschi L, Giles GG, van Leeuwen MT, Vajdic CM. A systematic review and meta-analysis of occupational exposures and risk of follicular lymphoma. Environ Res 2021;197:110887. [PMID: 33607095 DOI: 10.1016/j.envres.2021.110887] [Reference Citation Analysis]
26 Ren W, Li W, Ye X, Liu H, Pan-Hammarström Q. Distinct subtype distribution and somatic mutation spectrum of lymphomas in East Asia. Curr Opin Hematol 2017;24:367-76. [PMID: 28406802 DOI: 10.1097/MOH.0000000000000355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Rai KR, Jain P. Chronic lymphocytic leukemia (CLL)-Then and now. Am J Hematol 2016;91:330-40. [PMID: 26690614 DOI: 10.1002/ajh.24282] [Cited by in Crossref: 74] [Cited by in F6Publishing: 50] [Article Influence: 14.8] [Reference Citation Analysis]
28 Ghesquières H, Rossi C, Cherblanc F, Le Guyader-Peyrou S, Bijou F, Sujobert P, Fabbro-Peray P, Bernier A, Belot A, Chartier L, Fornecker LM, Baldi I, Bouabdallah K, Laurent C, Oberic L, Morineau N, Le Gouill S, Morschhauser F, Haioun C, Damaj G, Guidez S, Labouré G, Fitoussi O, Lebras L, Gressin R, Salles G, Ysebaert L, Monnereau A. A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort. BMC Public Health 2021;21:432. [PMID: 33653294 DOI: 10.1186/s12889-021-10433-4] [Reference Citation Analysis]
29 Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. The Lancet 2017;390:298-310. [DOI: 10.1016/s0140-6736(16)32407-2] [Cited by in Crossref: 158] [Cited by in F6Publishing: 71] [Article Influence: 39.5] [Reference Citation Analysis]
30 Chan JY, Ng AYJ, Cheng CL, Nairismägi ML, Venkatesh B, Cheah DMZ, Li ST, Chan SH, Ngeow J, Laurensia Y, Lim JQ, Pang JWL, Nagarajan S, Song T, Chia B, Tan J, Huang D, Goh YT, Poon E, Somasundaram N, Tao M, Quek RHH, Farid M, Khor CC, Bei JX, Tan SY, Lim ST, Ong CK, Tang T. Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphoma. Blood Cancer J 2018;8:111. [PMID: 30420729 DOI: 10.1038/s41408-018-0149-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
31 Kleinstern G, Camp NJ, Goldin LR, Vachon CM, Vajdic CM, de Sanjose S, Weinberg JB, Benavente Y, Casabonne D, Liebow M, Nieters A, Hjalgrim H, Melbye M, Glimelius B, Adami HO, Boffetta P, Brennan P, Maynadie M, McKay J, Cocco PL, Shanafelt TD, Call TG, Norman AD, Hanson C, Robinson D, Chaffee KG, Brooks-Wilson AR, Monnereau A, Clavel J, Glenn M, Curtin K, Conde L, Bracci PM, Morton LM, Cozen W, Severson RK, Chanock SJ, Spinelli JJ, Johnston JB, Rothman N, Skibola CF, Leis JF, Kay NE, Smedby KE, Berndt SI, Cerhan JR, Caporaso N, Slager SL. Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. Blood 2018;131:2541-51. [PMID: 29674426 DOI: 10.1182/blood-2017-11-814608] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
32 Clemmensen SB, Harris JR, Mengel-From J, Bonat WH, Frederiksen H, Kaprio J, Hjelmborg JVB. Familial Risk and Heritability of Hematologic Malignancies in the Nordic Twin Study of Cancer. Cancers (Basel) 2021;13:3023. [PMID: 34208754 DOI: 10.3390/cancers13123023] [Reference Citation Analysis]
33 Carballo-zarate A, Garcia-horton A, Palma-berre L, Ramos-salazar P, Sanchez-verin-lucio R, Valenzuela-tamariz J, Molinar-horcasitas L, Lazo-langner A, Zarate-osorno A. Distribution of lymphomas in Mexico: a multicenter descriptive study. J Hematopathol 2018;11:99-105. [DOI: 10.1007/s12308-018-0336-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Li Y, Mao M, Liu H, Wang X, Kou Z, Nie Y, Wang Y, Wang Z, Huang Q, Lang T, Gu Z, An L, Zhang X, Fu L. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations. Molecular and Cellular Probes 2019;47:101436. [DOI: 10.1016/j.mcp.2019.101436] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
35 Nanthakwang N, Rattarittamrong E, Rattanathammethee T, Chai-Adisaksopha C, Tantiworawit A, Norrasethada L, Ya-In C. Clinicopathological study and outcomes of primary extranodal lymphoma. Hematol Rep 2019;11:8227. [PMID: 31871611 DOI: 10.4081/hr.2019.8227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Neznanov NG, Kibitov AO, Rukavishnikov GV, Mazo GE. The prognostic role of depression as a predictor of chronic somatic diseases manifestation. Terapevticheskii arkhiv 2018;90:122-32. [DOI: 10.26442/00403660.2018.12.000019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
37 Smedby KE, Ponzoni M. The aetiology of B-cell lymphoid malignancies with a focus on chronic inflammation and infections. J Intern Med. 2017;282:360-370. [PMID: 28875507 DOI: 10.1111/joim.12684] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
38 Mangaonkar AA, Patnaik MM. Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers. Mayo Clin Proc 2020;95:1482-98. [PMID: 32571604 DOI: 10.1016/j.mayocp.2019.12.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
39 England CG, Rui L, Cai W. Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies. Eur J Nucl Med Mol Imaging 2017;44:517-32. [PMID: 27844106 DOI: 10.1007/s00259-016-3560-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
40 Kusminsky G, Abriata G, Forman D, Sierra MS. Hodgkin lymphoma burden in Central and South America. Cancer Epidemiology 2016;44:S158-67. [DOI: 10.1016/j.canep.2016.07.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Scott AJ, Tokaz MC, Jacobs MF, Chinnaiyan AM, Phillips TJ, Wilcox RA. Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series. Fam Cancer 2021;20:61-5. [PMID: 32504211 DOI: 10.1007/s10689-020-00192-3] [Reference Citation Analysis]
42 Cerhan JR. Epidemiology of Follicular Lymphoma. Hematol Oncol Clin North Am 2020;34:631-46. [PMID: 32586570 DOI: 10.1016/j.hoc.2020.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
43 Buhtoiarov IN. Pediatric Lymphoma. Pediatr Rev 2017;38:410-23. [PMID: 28864732 DOI: 10.1542/pir.2016-0152] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]